Hims reports 2025 earnings, shares details on GLP-1 pill decisionsnews2026-02-24T08:00:50+00:00February 24th, 2026|Endpoints News|
A federal experiment opens up a new market for digital health — if it worksnews2026-02-23T15:00:15+00:00February 23rd, 2026|Endpoints News|
When a health tech startup gets stuck in regulatory limbonews2026-02-19T19:16:19+00:00February 19th, 2026|Endpoints News|
Hims to buy Australia’s Eucalyptus for $240M upfront in global pushnews2026-02-19T14:52:28+00:00February 19th, 2026|Endpoints News|
Why clinical AI startup Kintsugi shut downnews2026-02-18T20:43:12+00:00February 18th, 2026|Endpoints News|
How employers feel about the state of healthcare (and GLP-1s)news2026-02-12T16:07:36+00:00February 12th, 2026|Endpoints News|
Hinge Health is looking to build AI tools for mental health supportnews2026-02-12T02:14:33+00:00February 12th, 2026|Endpoints News|
Oscar Health expects explosive growth for 2026, but it comes with a risknews2026-02-11T14:32:46+00:00February 11th, 2026|Endpoints News|
